Homologous recombination deficiency (HRD) is associated with better prognosis and possibly causes a non‐inflamed tumour microenvironment in nasopharyngeal carcinoma
Abstract Homologous recombination deficiency (HRD) score is a reliable indicator of genomic instability. The significance of HRD in nasopharyngeal carcinoma (NPC), particularly its influence on prognosis and the immune microenvironment, has yet to be adequately explored. Understanding HRD status com...
Guardado en:
Autores principales: | Xinyi Zhou (Autor), Haoxuan Ying (Autor), Yujie Sun (Autor), Wenda Zhang (Autor), Peng Luo (Autor), Shuhan Zhu (Autor), Jian Zhang (Autor) |
---|---|
Formato: | Libro |
Publicado: |
Wiley,
2024-09-01T00:00:00Z.
|
Materias: | |
Acceso en línea: | Connect to this object online. |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A novel targeted NGS panel identifies numerous homologous recombination deficiency (HRD)-associated gene mutations in addition to known BRCA mutations
por: Anne Vogel, et al.
Publicado: (2024) -
Homologous Recombination Pathway Alternation Predicts Prognosis of Colorectal Cancer With Chemotherapy
por: Yan Lin, et al.
Publicado: (2022) -
PANoptosis-Relevant Subgroups Predicts Prognosis and Characterizes the Tumour Microenvironment in Ovarian Cancer
por: Chen Y, et al.
Publicado: (2024) -
Enhanced photodynamic therapy/photothermo therapy for nasopharyngeal carcinoma via a tumour microenvironment-responsive self-oxygenated drug delivery system
por: Nan Wu, et al.
Publicado: (2022) -
A transcriptional signature detects homologous recombination deficiency in pancreatic cancer at the individual level
por: Shuping Zhuang, et al.
Publicado: (2021)